Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Syros Pharmaceuticals (SYRS)

17.43 +0.57 (+3.38%)

6/23/2017  4:00pm

Open:

18.43

Pre. Close:

16.86

High:

18.45

Low:

16.18

Volume:

942,978

Market Cap:

456.32M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

19.24 - 19.33

19.33 - 19.79

Low:

14.74 - 14.83

14.83 - 15.29

Close:

15.87 - 16.13

16.13 - 17.44

Technical analysis  (as of: 2017-06-23 4:02:11 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 22.45     One year: 26.22

Support:

Support1: 15.99    Support2: 14.00

Resistance:

Resistance1: 19.22    Resistance2: 22.45

Pivot:

16.49

Moving Averages:

MA(5): 17.49     MA(20): 16.33

MA(100): 14.16     MA(250):

MACD:

MACD(12,26): 0.52     Signal(12,26,9): 0.41

%K %D:

%K(14,3): 59.82     %D(3): 63.88

RSI:

RSI(14): 56.56

52-Week:

High: 21.50  Low: 8.16  Change(%): -4.1

Average Vol(K):

3-Month: 43  10-Days 107

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
SYRS has closed below upper band by 30.7%. Bollinger Bands are 70.1% wider than normal. The large width of the bands suggest high volatility as compared to SYRS's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

Mon, 06 Jun 2016 12:25:14 GMT
16.86

Mon, 19 Jun 2017 12:00:00 GMT
Syros Presents Discovery of Key Genes Controlling the Autoimmune Response in ...

Fri, 23 Jun 2017 15:00:00 GMT
Syros Pharmaceuticals Inc (SYRS) Seeing Increased Action in Session

Fri, 23 Jun 2017 16:18:45 GMT
Syros Pharmaceuticals, Inc. (NasdaqGS:SYRS): A Look at the Company's Profitability

Mon, 09 Jan 2017 13:35:37 GMT
Syros Pharmaceuticals Announces 2017 Strategic Priorities and Goals

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biopharmaceuticals

Shares Out. (M)

26.18

Shares Float (M)

9.93

% Held by Insiders

% Held by Institutions

Shares Short (K)

216

Shares Short Prior Month (K)

210

Stock Financials

EPS

-2.820

EPS Est. Current Year

-3.040

EPS Est. Next Year

-3.900

EPS Est. Next Quarter

-0.560

Forward EPS

-3.903

Book Value (p.s.)

2.990

PEG Ratio

Profit Margin

Operating Margin

-3451.34

Return on Assets (ttm)

-41.1

Return on Equity (ttm)

-72.6

Qtrly Rev. Growth

Gross Profit (p.s.)

0.012

Sales Per Share

EBITDA (p.s.)

-1.819

Qtrly Earnings Growth

Operating Cash Flow (M)

-42.74

Levered Free Cash Flow (M)

-25.46

FoxReading.com

Valuation

P/E

-6.17

P/E Growth Ratio

0.03

P/BV

5.82

P/S

5697422336.00

P/CF

-10.66

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.